Traws Pharma, Inc. — Director's Dealing 2023

Oct 27, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2023-10-02

Reporting Person: Moyo Victor M (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-10-02	Stock Option (right to purchase)	$0.74	A	125000	Acquired	2033-10-02	Common Stock (125000)	Direct

Footnotes

F1: These options vest over 4 years, 25% on the first anniversary of the grant and thereafter in 36 equal monthly installments over the next 3 years.